Corrigendum to "Expert consensus paper on the use of Vedolizumab for the management of patients with moderate-to-severe Inflammatory Bowel Disease" [Dig. Liver Dis. 48 (2016) 360-370]

Dig Liver Dis. 2016 Sep;48(9):1103. doi: 10.1016/j.dld.2016.06.015.
No abstract available

Publication types

  • Published Erratum